Clinical Biotechnology Suppliers In North America

We are a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. ...

Origin is a privately-held, clinical-stage biotechnology company founded in June 2010 to develop and commercialize a novel, patented medical technology - delivering therapeutic molecules generated right at the point of care. Our technology is based ...

Capricor is Developing Transformative Cell and Exosome-based Therapeutics for the Treatment and Prevention of Diseases. Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and ...

Filtricine, Inc. is a clinical stage biotechnology company focused on developing novel products for cancer management. We are backed by venture capital and located in the San Francisco Bay Area of California. We are developing an innovative way to ...

Eupraxia Pharmaceuticals is a clinical-stage biotechnology company leveraging proprietary and innovative delivery technology with the goal of providing the right dose of drug in the right place for the right amount of time in indications with a high ...

Rebiotix Inc., a Ferring Company, is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating diseases by harnessing the power of the human microbiome. The company is on the forefront of an exciting potential ...

As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...

Istari Oncology, Inc., is a clinical-stage biotechnology company developing innovative immunotherapies for the treatment of patients with solid tumors. Istari has built a passionate and experienced leadership team focused on clinical trial strategy ...

Hemostemix (TSX V:HEM; OTCQB:HMTXF) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. Hemostemix’s proprietary platform technology is based on more ...

Transgene is a clinical-stage biotechnology company focused on designing and developing novel immunotherapeutics. Every day, we push the boundaries of innovation with our therapeutic vaccines and oncolytic viruses, to design better treatments for ...

LayerBio, Inc. is clinical-stage biotechnology company developing innovative therapies to address unmet needs in the field of ophthalmology and other therapeutic areas. LayerBio was founded as a spinoff of Massachusetts Institute of Technology (MIT) ...

Based in Princeton, NJ, Biopticon is a leading developer, manufacturer, and marketer of next-generation measurement and data management systems for pre-clinical animal studies. Biopticon's proprietary solutions give researchers performing oncology ...

Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...

Lynx Biosciences, Inc. (LynxBio) is a clinical-stage biotechnology company combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates ...

In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly ...

3D Bio is a clinical-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting and materials technologies to deliver safe, functional and personalized living tissues and organs, engineered on-demand for patients. ...

Advanced Instruments is dedicated to increasing productivity and ensuring quality in the biotechnology, pharmaceutical, clinical and food & beverage industries. With a focus on innovations that anticipate and overcome customer pain points, we help ...

Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...

We are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering to industrialize drug discovery. We are leveraging new technology to ...

HRGN is a clinical-stage biotechnology company that uses a patient’s own stem cells that are grown on a hollow tubular scaffold to regenerate organ tissue damaged from cancer, trauma, birth defects or other diseases. The patient’s stem ...